Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05625802 · ClinicalTrials.gov registry record · Phase 2
Erector Spinae Plane Block for Uncomplicated Renal Colic
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT05625802 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 5 participants.
The verdict
NCT05625802, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research study is to determine how well the Erector Spinae Plane Block (ESPB) works for kidney stone pain and any possible side effects.
Interventions
- DRUG Ropivacaine
- PROCEDURE Erector Spinae Plane Block (ESPB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-02-08 |
| Est. Completion | 2024-02-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05625802
The ClinicalTrials.gov registry entry for NCT05625802 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine is the first listed.
NCT05625802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05625802 about?
NCT05625802 is a clinical study titled "Erector Spinae Plane Block for Uncomplicated Renal Colic". This research study is to determine how well the Erector Spinae Plane Block (ESPB) works for kidney stone pain and any possible side effects.
What is the current status of trial NCT05625802?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2023-02-08. Estimated completion is 2024-02-02.
What interventions are being tested in trial NCT05625802?
The interventions under investigation include: Ropivacaine (DRUG), Erector Spinae Plane Block (ESPB) (PROCEDURE).
Who is sponsoring clinical trial NCT05625802?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.